Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01833702 · ClinicalTrials.gov registry record

Use of a Mobile-based App for SCD Patients

A clinical trial of Chronic Pain and Sickle Cell Disease, sponsored by Duke University.

Completed
Registry status
21
Enrollment target
1
Study location

NCT01833702: Completed study of Chronic Pain and Sickle Cell Disease, sponsored by Duke University.

NCT01833702 is a study of Chronic Pain and Sickle Cell Disease that has completed, run by Duke University. The registered enrollment target is 21 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01833702, a study of Chronic Pain and Sickle Cell Disease, has completed, sponsored by Duke University.

COMPLETED
Registry status
21 participants
Enrollment target
1
Study location

Study Summary

The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily. The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to recording these levels daily. The study will track patients' assessment of their pain, actions taken, and outcomes related to pain management and provider involvement. This study will attempt to collect information about differences in the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an Android or iOS operating system.

Primary Outcome

Patients are able to use a mobile device to record daily symptoms, including pain, and interventions, including medication administration.

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2012-06
Est. Completion 2014-05
Duke University

1,725 total trials

What the finished NCT01833702 record still lists

NCT01833702 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 0 interventions.

NCT01833702 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01833702 about?

NCT01833702 is a clinical study titled "Use of a Mobile-based App for SCD Patients". The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily. The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to ...

What is the current status of trial NCT01833702?

This trial is currently completed. The enrollment target is 21 participants. The study started on 2012-06. Estimated completion is 2014-05.

What conditions does trial NCT01833702 study?

This clinical trial studies the following conditions: Chronic Pain, Sickle Cell Disease.

Who is sponsoring clinical trial NCT01833702?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01833702 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01833702's enrollment target sits among peer trials

21 268th of 301 higher than 32 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01833702, the US trial registry maintained by the National Library of Medicine. NCT01833702 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.